BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katz AP, Civantos FJ, Sargi Z, Leibowitz JM, Nicolli EA, Weed D, Moskovitz AE, Civantos AM, Andrews DM, Martinez O, Thomas GR. False-positive reverse transcriptase polymerase chain reaction screening for SARS-CoV-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications. Head Neck. 2020;42:1621-1628. [PMID: 32530131 DOI: 10.1002/hed.26317] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Katz AP, Civantos FJ, Sargi Z, Leibowitz JM, Nicolli EA, Weed D, Moskovitz AE, Civantos AM, Andrews DM, Martinez O, Thomas GR. False-positive reverse transcriptase polymerase chain reaction screening for SARS-CoV-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications. Head Neck. 2020;42:1621-1628. [PMID: 32530131 DOI: 10.1002/hed.26317] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
2 Roy S. Physicians' Dilemma of False-Positive RT-PCR for COVID-19: a Case Report. SN Compr Clin Med 2021;:1-4. [PMID: 33426468 DOI: 10.1007/s42399-020-00655-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Jagtap S, K R, Valloly P, Sharma R, Maurya S, Gaigore A, Ardhya C, Biligi DS, Desiraju BK, Natchu UCM, Saini DK, Roy R. Evaluation of spike protein antigens for SARS-CoV-2 serology. J Virol Methods 2021;296:114222. [PMID: 34197839 DOI: 10.1016/j.jviromet.2021.114222] [Reference Citation Analysis]
4 [DOI: 10.1101/2020.04.26.20080911] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 Zhang K, Li J, Fan Z, Li H, Xu JJ. "Covalent biosensing" enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2. Chem Commun (Camb) 2021;57:10771-4. [PMID: 34585685 DOI: 10.1039/d1cc03686f] [Reference Citation Analysis]
6 Agoti CN, Mutunga M, Lambisia AW, Kimani D, Cheruiyot R, Kiyuka P, Lewa C, Gicheru E, Tendwa M, Said Mohammed K, Osoti V, Makale J, Tawa B, Odundo C, Cheruiyot W, Nyamu W, Gumbi W, Mwacharo J, Nyamako L, Otieno E, Amadi D, Thoya J, Karani A, Mugo D, Musyoki J, Gumba H, Mwarumba S, M Gichuki B, Njuguna S, Riako D, Mutua S, Gitonga JN, Sein Y, Bartilol B, Mwangi SJ, O Omuoyo D, M Morobe J, de Laurent ZR, Bejon P, Ochola-Oyier LI, Tsofa B. Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast. Wellcome Open Res 2020;5:186. [PMID: 33134555 DOI: 10.12688/wellcomeopenres.16113.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hueston L, Kok J, Guibone A, McDonald D, Hone G, Goodwin J, Carter I, Basile K, Sandaradura I, Maddocks S, Sintchenko V, Gilroy N, Chen S, Dwyer DE, O'Sullivan MVN. The Antibody Response to SARS-CoV-2 Infection. Open Forum Infect Dis 2020;7:ofaa387. [PMID: 32989419 DOI: 10.1093/ofid/ofaa387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
8 Stessel B, Callebaut I, Polus F, Geebelen L, Evers S, Ory JP, Magerman K, Souverijns G, Braeken G, Ramaekers D, Cox J. Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study. Ann Med 2021;53:337-44. [PMID: 33583292 DOI: 10.1080/07853890.2021.1878272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sullivan A, Alfego D, Poirier B, Williams J, Adcock D, Letovsky S. Follow-Up SARS-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US. Front Public Health 2021;9:679012. [PMID: 34136460 DOI: 10.3389/fpubh.2021.679012] [Reference Citation Analysis]
10 Griffin JH, Downard KM. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review. Trends Analyt Chem 2021;142:116328. [PMID: 33994605 DOI: 10.1016/j.trac.2021.116328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Moreno-Pérez O, Merino E, Chico-Sánchez P, Gras-Valentí P, Sánchez-Payá J; COVID19-ALC Research Group. Effectiveness of a SARS-CoV-2 infection prevention model in elective surgery patients - a prospective study: does universal screening make sense? J Hosp Infect 2021;115:27-31. [PMID: 33992743 DOI: 10.1016/j.jhin.2021.04.032] [Reference Citation Analysis]
12 Cengel F, Gurkan O, Calik M, Demirkol MA, Sargin Altunok E, Kaya MF, Nacar Dogan S. Diagnosis of the coronavirus disease 2019 with chest computed tomography: A retrospective inter-observer agreement study between radiologists and clinicians. Hong Kong Journal of Emergency Medicine 2021;28:15-21. [DOI: 10.1177/1024907920968648] [Reference Citation Analysis]
13 Sicsic I Jr, Chacon AR, Zaw M, Ascher K, Abreu A, Chediak A. A case of SARS-CoV-2 reinfection in a patient with obstructive sleep apnea managed with telemedicine. BMJ Case Rep 2021;14:e240496. [PMID: 33526540 DOI: 10.1136/bcr-2020-240496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hasan T, Lim HL, Case J, Hueston L, Bag S, Dwyer DE, O'Sullivan MVN. The utility of SARS-CoV-2-specific serology in COVID-19 diagnosis. Aust N Z J Public Health 2021. [PMID: 34761846 DOI: 10.1111/1753-6405.13155] [Reference Citation Analysis]
15 Agoti CN, Mutunga M, Lambisia AW, Kimani D, Cheruiyot R, Kiyuka P, Lewa C, Gicheru E, Tendwa M, Said Mohammed K, Osoti V, Makale J, Tawa B, Odundo C, Cheruiyot W, Nyamu W, Gumbi W, Mwacharo J, Nyamako L, Otieno E, Amadi D, Thoya J, Karani A, Mugo D, Musyoki J, Gumba H, Mwarumba S, M Gichuki B, Njuguna S, Riako D, Mutua S, Gitonga JN, Sein Y, Bartilol B, Mwangi SJ, O Omuoyo D, M Morobe J, de Laurent ZR, Bejon P, Ochola-Oyier LI, Tsofa B. Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast. Wellcome Open Res 2020;5:186. [PMID: 33134555 DOI: 10.12688/wellcomeopenres.16113.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Braunstein GD, Schwartz L, Hymel P, Fielding J. False Positive Results With SARS-CoV-2 RT-PCR Tests and How to Evaluate a RT-PCR-Positive Test for the Possibility of a False Positive Result. J Occup Environ Med 2021;63:e159-62. [PMID: 33405498 DOI: 10.1097/JOM.0000000000002138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Abueg M, Hinch R, Wu N, Liu L, Probert W, Wu A, Eastham P, Shafi Y, Rosencrantz M, Dikovsky M, Cheng Z, Nurtay A, Abeler-Dörner L, Bonsall D, McConnell MV, O'Banion S, Fraser C. Modeling the effect of exposure notification and non-pharmaceutical interventions on COVID-19 transmission in Washington state. NPJ Digit Med 2021;4:49. [PMID: 33712693 DOI: 10.1038/s41746-021-00422-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
18 Yang S, Stanzione N, Uslan DZ, Garner OB, de St Maurice A. Clinical and Epidemiologic Evaluation of Inconclusive COVID-19 PCR Results Using a Quantitative Algorithm. Am J Clin Pathol 2021;155:376-80. [PMID: 33274731 DOI: 10.1093/ajcp/aqaa251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Verma HK. Radiological and clinical spectrum of COVID-19: A major concern for public health. World J Radiol 2021; 13(3): 53-63 [PMID: 33815683 DOI: 10.4329/wjr.v13.i3.53] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Younes S, Al-Jighefee H, Shurrab F, Al-Sadeq DW, Younes N, Dargham SR, Al-Dewik N, Qotba H, Syed M, Alnuaimi A, Yassine HM, Tang P, Abu-Raddad LJ, Nasrallah GK. Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals. Microorganisms 2021;9:245. [PMID: 33504067 DOI: 10.3390/microorganisms9020245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Al-awwal N, Dweik F, Mahdi S, El-dweik M, Anderson SH. A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time. Pathogens 2022;11:368. [DOI: 10.3390/pathogens11030368] [Reference Citation Analysis]
22 Florou Z, Zigra M, Kartalidis P, Tsilipounidaki K, Papadamou G, Belia A, Fthenakis GC, Petinaki E. Combination of rRT-PCR and Anti-Nucleocapsid/Anti-Spike Antibodies to Characterize Specimens with Very Low Viral SARs-CoV-2 Load: A Real-Life Experience. Microorganisms 2021;9:1263. [PMID: 34200837 DOI: 10.3390/microorganisms9061263] [Reference Citation Analysis]
23 Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis 2021;40:13-25. [PMID: 33113040 DOI: 10.1007/s10096-020-04088-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
24 Bi C, Ramos-Mandujano G, Tian Y, Hala S, Xu J, Mfarrej S, Esteban CR, Delicado EN, Alofi FS, Khogeer A, Hashem AM, Almontashiri NAM, Pain A, Izpisua Belmonte JC, Li M. Simultaneous detection and mutation surveillance of SARS-CoV-2 and multiple respiratory viruses by rapid field-deployable sequencing. Med (N Y) 2021;2:689-700.e4. [PMID: 33821249 DOI: 10.1016/j.medj.2021.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Goggin M, Vote B. Phacoemulsification and COVID-19 risk. Clin Exp Ophthalmol 2020;48:1131-2. [PMID: 33103364 DOI: 10.1111/ceo.13869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Bentley PM. Error rates in SARS-CoV-2 testing examined with Bayes' theorem. Heliyon 2021;7:e06905. [PMID: 33937546 DOI: 10.1016/j.heliyon.2021.e06905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Gwenzi W. Wastewater, waste, and water-based epidemiology (WWW-BE): A novel hypothesis and decision-support tool to unravel COVID-19 in low-income settings? Sci Total Environ 2021;806:150680. [PMID: 34599955 DOI: 10.1016/j.scitotenv.2021.150680] [Reference Citation Analysis]
28 Gededzha MP, Mampeule N, Jugwanth S, Zwane N, David A, Burgers WA, Blackburn JM, Grove JS, George JA, Sanne I, Scott L, Stevens W, Mayne ES. Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa. PLoS One 2021;16:e0252317. [PMID: 34161348 DOI: 10.1371/journal.pone.0252317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Szigeti R, Kellermayer R. Natural unblinding of BCG vaccination trials. Vaccine 2021;39:2017-9. [PMID: 33744042 DOI: 10.1016/j.vaccine.2021.03.039] [Reference Citation Analysis]
30 Falasca F, Sciandra I, Di Carlo D, Gentile M, Deales A, Antonelli G, Turriziani O. Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive? J Clin Virol 2020;133:104660. [PMID: 33126109 DOI: 10.1016/j.jcv.2020.104660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]